IGF1 and Miyoshi myopathy: In this study we identified IGFBP7, a secreted factor with BMP antagonistic activity [18], and binding sites for IGF-1, insulin [15], VEGFA [16] and activin A [17] as a potential novel player in the pathogenesis of MM, including myeloma bone disease.